American journal of respiratory and critical care medicine
-
Am. J. Respir. Crit. Care Med. · May 2014
Editorial CommentActive lifestyle: the next "smoking cessation"?
-
Am. J. Respir. Crit. Care Med. · May 2014
Multicenter Study Comparative StudyPathway From Central Obesity to Childhood Asthma: Physical Fitness and Sedentary Time Are Leading Factors.
Available prospective studies of obesity and asthma have used only body mass index (BMI) as an indicator for adiposity; studies using detailed obesity measures are lacking, and the role of physical fitness level and sedentary time remains unexplored in the link between obesity and asthma. ⋯ Central obesity measures should be incorporated in childhood asthma risk predictions. Children are encouraged to increase their physical fitness levels and reduce their sedentary time to prevent central obesity-related asthma.
-
Am. J. Respir. Crit. Care Med. · May 2014
Randomized Controlled Trial Multicenter StudyRisk Factors for Physical Impairment after Acute Lung Injury in a National, Multi-Center Study.
Existing studies of risk factors for physical impairments in acute lung injury (ALI) survivors were potentially limited by single-center design or relatively small sample size. ⋯ Patients had substantial impairments, from predicted values, for 6-minute-walk distance and SF-36 Physical Function outcome measures. Minimizing corticosteroid dose and implementing existing evidence-based methods to reduce duration of intensive care unit stay and associated patient immobilization may be important interventions for improving ALI survivors' physical outcomes.
-
Am. J. Respir. Crit. Care Med. · May 2014
Randomized Controlled TrialReduction of Bacterial Resistance with Inhaled Antibiotics in the ICU.
Multidrug-resistant organisms (MDRO) are the dominant airway pathogens in the intensive care unit (ICU) and present a major treatment challenge to intensivists. Aerosolized antibiotics (AA) result in airway concentrations of drug 100-fold greater than the minimal inhibitory concentration of most bacteria including MDRO. These levels, without systemic toxicity, may eradicate MDRO and reduce the pressure for selection of new resistant organisms. ⋯ In chronically intubated critically ill patients, AA successfully eradicated existing MDRO organisms and reduced the pressure from systemic agents for new respiratory resistance. Clinical trial registered with www.clinicaltrials.gov (NCT 01878643).